ArrowMark Colorado Holdings’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,534
Closed -$223K 334
2020
Q3
$223K Hold
1,534
﹤0.01% 325
2020
Q2
$227K Sell
1,534
-1,967
-56% -$291K ﹤0.01% 291
2020
Q1
$381K Sell
3,501
-1,076
-24% -$117K 0.01% 281
2019
Q4
$527K Hold
4,577
﹤0.01% 288
2019
Q3
$368K Sell
4,577
-12,475
-73% -$1M ﹤0.01% 295
2019
Q2
$1.24M Buy
17,052
+29
+0.2% +$2.1K 0.01% 265
2019
Q1
$1.59M Sell
17,023
-17,921
-51% -$1.67M 0.02% 254
2018
Q4
$2.55M Hold
34,944
0.03% 242
2018
Q3
$3.06M Hold
34,944
0.03% 245
2018
Q2
$3.44M Sell
34,944
-1,223
-3% -$120K 0.03% 235
2018
Q1
$4.31M Sell
36,167
-272,872
-88% -$32.5M 0.04% 213
2017
Q4
$39.3M Sell
309,039
-194,850
-39% -$24.8M 0.4% 84
2017
Q3
$59.2M Sell
503,889
-34,400
-6% -$4.04M 0.67% 49
2017
Q2
$42.9M Sell
538,289
-67,854
-11% -$5.41M 0.53% 68
2017
Q1
$31.1M Sell
606,143
-86,593
-13% -$4.44M 0.42% 84
2016
Q4
$25.9M Buy
692,736
+301,877
+77% +$11.3M 0.41% 82
2016
Q3
$26.5M Buy
390,859
+19,309
+5% +$1.31M 0.48% 73
2016
Q2
$20.6M Buy
371,550
+60,977
+20% +$3.38M 0.42% 84
2016
Q1
$19.5M Buy
310,573
+133,891
+76% +$8.4M 0.43% 81
2015
Q4
$16.6M Buy
176,682
+159,081
+904% +$15M 0.45% 74
2015
Q3
$1.41M Buy
17,601
+6,286
+56% +$505K 0.04% 210
2015
Q2
$1.36M Hold
11,315
0.03% 222
2015
Q1
$1.18M Sell
11,315
-159,092
-93% -$16.6M 0.03% 219
2014
Q4
$16.5M Sell
170,407
-51,533
-23% -$5M 0.42% 72
2014
Q3
$17.3M Sell
221,940
-38,374
-15% -$3M 0.48% 69
2014
Q2
$16.4M Buy
260,314
+129,747
+99% +$8.2M 0.47% 78
2014
Q1
$8.77M Sell
130,567
-1,412
-1% -$94.8K 0.28% 123
2013
Q4
$8.49M Buy
131,979
+96,979
+277% +$6.24M 0.26% 128
2013
Q3
$2.24M Sell
35,000
-8,400
-19% -$538K 0.07% 173
2013
Q2
$1.35M Buy
+43,400
New +$1.35M 0.36% 55